Calling the shots
Disheartened by tales from family and friends frustrated by his home state of Pennsylvania’s vaccine distribution system, Seth Rubinstein ’22, a second year student at Harvard Law School, knew he wanted to get involved.
The shape of discrimination
Harvard Law alum Daniel Aaron ’20 thinks high obesity rates among people of color may be another legacy of ongoing racism in America.
More Harvard Law faculty and alumni tapped to serve in the Biden administration
Since President Joe Biden took office in January, dozens of Harvard Law community members, including faculty and alumni, have been tapped to serve in high-profile positions in his administration
Petrie-Flom Center assembles new advisory board, including Moderna consultant, WHO legal counsel, and hospital executive
On February 11, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced the formation of its new advisory board.
Should smokers be prioritized for COVID vaccine?
Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine? Harvard Law public health expert Carmel Shachar says the answer is yes.
Harvard and Yale health law centers partner for COVID-19 seminar series
The Petrie-Flom Center at Harvard Law School is joining forces with the Solomon Center for Health Law and Policy, its counterpart at Yale Law School, to host a seminar series reflecting on ethical and legal issues raised by the COVID-19 pandemic.
What you should know about the COVID-19 vaccine
Public health expert Carmel Shachar discusses the COVID-19 vaccine, who is likely to get it first, and whether people can be required to get vaccinated.
Detecting dementia
Experts gathered this week to discuss the ethical, social, and legal implications of technological advancements that facilitate the early detection of dementia.
Nudging organ donation in the United States
Cass Sunstein ’78, Robert Walmsley University Professor and former Administrator of the White House Office of Information and Regulatory Affairs in the Obama administration, believes “Nudge theory” might help bridge the gap between supply and demand for organ transplants.
Building public trust in a coronavirus vaccine
In an interview with Harvard Law Today, Carmel Shachar, executive director of the Petrie-Flom Center for Health Policy, Biotechnology, and Bioethics at Harvard Law School, says that political interference in the FDA’s process for ensuring that a vaccine is both safe and effective “opens the door to a public health disaster.”